Omega Therapeutics (OMGA) Short Interest Ratio & Short Volume → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free OMGA Stock Alerts $1.96 -0.21 (-9.68%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Omega Therapeutics Short Interest DataCurrent Short Volume4,500,000 sharesPrevious Short Volume4,430,000 sharesChange Vs. Previous Month+1.58%Dollar Volume Sold Short$10.04 millionShort Interest Ratio / Days to Cover11.1Last Record DateApril 30, 2024Outstanding Shares55,150,000 sharesFloat Size20,420,000 sharesShort Percent of Float22.04%Today's Trading Volume519,333 sharesAverage Trading Volume350,265 sharesToday's Volume Vs. Average148% Short Selling Omega Therapeutics ? Sign up to receive the latest short interest report for Omega Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOMGA Short Interest Over TimeOMGA Days to Cover Over TimeOMGA Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Omega Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,500,000 shares $10.04 million +1.6%22.0%11.1 $2.23 4/15/20244,430,000 shares $11.14 million +9.7%21.7%9.6 $2.52 3/31/20244,040,000 shares $14.75 million +4.1%19.8%5.3 $3.65 3/15/20243,880,000 shares $14.05 million +4.3%19.0%1.8 $3.62 2/29/20243,720,000 shares $15.29 million +12.4%18.2%1.8 $4.11 2/15/20243,310,000 shares $14.07 million +5.8%16.2%1.6 $4.25 Get the Latest News and Ratings for OMGA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,130,000 shares $11.42 million -13.5%14.7%1.6 $3.65 1/15/20243,620,000 shares $15.75 million +138.2%17.0%1.9 $4.35 12/31/20231,520,000 shares $4.58 million +2.7%7.1%0.9 $3.01 12/15/20231,480,000 shares $3.66 million -11.9%6.9%5.9 $2.47 11/30/20231,680,000 shares $3.85 million +0.6%7.9%7.5 $2.29 11/15/20231,670,000 shares $3.11 million -13.0%7.8%8.6 $1.86 10/31/20231,920,000 shares $2.63 million -6.8%9.0%10.3 $1.37 10/15/20232,060,000 shares $3.61 million +7.9%9.7%14 $1.75 9/30/20231,910,000 shares $4.11 million -11.2%9.0%13.8 $2.15 9/15/20232,150,000 shares $7.10 million +4.9%10.1%12.9 $3.30 8/31/20232,050,000 shares $7.52 million +12.6%9.6%11.9 $3.67 8/15/20231,820,000 shares $6.30 million +4.0%8.6%10.5 $3.46 7/31/20231,750,000 shares $9.78 million +7.4%8.2%10.2 $5.59 7/15/20231,630,000 shares $7.53 million +15.6%7.6%9.9 $4.62 6/30/20231,410,000 shares $7.90 million +33.0%6.6%8.8 $5.60 6/15/20231,060,000 shares $8.43 million +1.0%5.0%7 $7.95 5/31/20231,050,000 shares $7.97 million +8.2%6.4%10.4 $7.59 5/15/2023970,900 shares $8.23 million -1.9%6.7%10.3 $8.48 4/30/2023989,900 shares $7.58 million +7.2%6.5%10.5 $7.66 4/15/2023923,600 shares $6.98 million +34.0%6.0%10.2 $7.56 3/31/2023689,300 shares $4.16 million +65.1%4.5%7.2 $6.03 3/15/2023417,600 shares $2.83 million +10.8%2.7%5.2 $6.78 2/28/2023376,800 shares $2.43 million -5.0%2.2%5.9 $6.46 2/15/2023396,800 shares $2.20 million +14.3%2.0%6.6 $5.55 1/31/2023347,200 shares $2.73 million +6.3%2.0%6.1 $7.85 1/15/2023326,600 shares $2.83 million +3.5%1.8%6.6 $8.65 12/30/2022315,700 shares $1.80 million +0.1%1.8%8.2 $5.71 12/15/2022315,500 shares $1.92 million -3.9%1.8%7.3 $6.10 11/30/2022328,300 shares $2.30 million -6.4%1.9%5 $7.00 11/15/2022350,800 shares $2.17 million -6.7%2.0%5.4 $6.20 10/31/2022375,900 shares $1.81 million +2.2%2.1%5.2 $4.81 10/15/2022368,000 shares $1.69 million +15.0%2.1%4.7 $4.60 9/30/2022320,100 shares $1.73 million +15.3%1.8%3.8 $5.42 9/15/2022277,600 shares $1.71 million -14.0%1.6%2 $6.17[URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond OMGA Short Interest - Frequently Asked Questions What is Omega Therapeutics' current short interest? Short interest is the volume of Omega Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 4,500,000 shares of OMGA short. 22.04% of Omega Therapeutics' shares are currently sold short. Learn More on Omega Therapeutics' current short interest. What is a good short interest ratio for Omega Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OMGA shares currently have a short interest ratio of 11.0. Learn More on Omega Therapeutics's short interest ratio. What is a good short interest percentage for Omega Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.04% of Omega Therapeutics' floating shares are currently sold short. Is Omega Therapeutics' short interest increasing or decreasing? Omega Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 4,500,000 shares, an increase of 1.6% from the previous total of 4,430,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Omega Therapeutics' float size? Omega Therapeutics currently has issued a total of 55,150,000 shares. Some of Omega Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Omega Therapeutics currently has a public float of 20,420,000 shares. How does Omega Therapeutics' short interest compare to its competitors? 22.04% of Omega Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Omega Therapeutics: Vigil Neuroscience, Inc. (4.61%), aTyr Pharma, Inc. (0.92%), Sangamo Therapeutics, Inc. (6.92%), bluebird bio, Inc. (29.14%), Karyopharm Therapeutics Inc. (14.59%), DBV Technologies S.A. (0.28%), Gritstone bio, Inc. (15.43%), Vaxart, Inc. (10.44%), Outlook Therapeutics, Inc. (7.65%), Molecular Partners AG (0.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Omega Therapeutics stock? Short selling OMGA is an investing strategy that aims to generate trading profit from Omega Therapeutics as its price is falling. OMGA shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Omega Therapeutics? A short squeeze for Omega Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OMGA, which in turn drives the price of the stock up even further. How often is Omega Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OMGA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: VIGL Short Interest LIFE Short Interest SGMO Short Interest BLUE Short Interest KPTI Short Interest DBVT Short Interest GRTS Short Interest VXRT Short Interest OTLK Short Interest MOLN Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OMGA) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBill Clinton Backing Biden Replacement???The Freeport Society